A Polypill for Secondary Prevention of Ischemic Heart Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.

Also called NCT03541109

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03541109
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03541109. Randomized; no masking; primary purpose treatment. Start 2019-05-20 (actual); primary completion 2023-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Polypill for Secondary Prevention of Ischemic Heart Disease
Condition
Acute Myocardial Infarction
Condition
ST Elevation Myocardial Infarction
Condition
Non-ST Elevation Myocardial Infarction
Intervention (Drug)
Polypill
Lead sponsor
Isfahan University of Medical Sciences (class: other)
Collaborator
Tehran University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct03541109
Content hash
b947f02b4b0d8bd5e5231eeae5867b756e66b8387ebb63c42856f893adddfc78